Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partnership for Microsoft LONDON — The data scientists and developers behind a ground-breaking microbiome data platform, today, announced their partnership with Microsoft Genomics, a Microsoft Azure service dedicated to meeting the computational challenges of the genomics era. […]
Distributor will supply Chirascan circular dichroism spectrometers and SX stopped-flow spectrometers to Ireland and Northern Ireland Surrey, UK and Dublin, IRELAND: Applied Photophysics, a leading provider of systems for biophysical characterization of biomolecules, today announced that it has signed a distribution agreement with material characterisation specialist, Particular Sciences. The distributor will supply industry and researchers in both […]
MILPITAS, Calif.–Applied StemCell, Inc. (ASC), a leading gene-editing company, announced that it has joined the National Institute of Standards and Technology (NIST) Genome Editing Consortium. Applied StemCell brings to the Consortium its expertise in TARGATT™ CRISPR/Cas9 gene-editing tools and induced pluripotent stem cell (iPSC) technology for the advancement of drug discovery and therapeutic applications. As part […]
Cambridge, UK – Cresset, innovative provider of software and contract research services for small molecule discovery and design, and Elixir Software, provider of real-time workflow tracking applications, have formed an alliance whereby the combination of their technologies will form the basis of a new groundbreaking application, which will radically increase the efficiency of drug discovery by […]
Hedera’s Next-generation Distributed Ledger Technology Moves Beyond Traditional Blockchain to Provide Certara with a Near Real-time, Public, Scalable Platform to Address Key Clinical Research, Regulatory Reporting and Supply Chain Challenges PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it has formed a […]
MINNEAPOLIS, Oct. 12, 2018 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement with Micropoint Bioscience of Shenzhen, China. Chuck Kummeth, President and CEO of Bio-Techne, Yan Pingyi, Chairman of Micropoint Bioscience, and Wang Bin, Executive Vice President, Shenzhen Association of Medical Devices, all attended the meeting and signing ceremony. Micropoint Bioscience is a […]
Royalty bearing license agreement to commercialise a product incorporating the Affimer technology Wetherby and Cambridge, UK, 10 October 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a commercial license with New England Biolabs® (NEB®) (Ipswich MA, USA), a global leader in the discovery and production of enzymes […]
Menlo Park, CA – Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced an extension to their contract with the US Department of Veterans Affairs (VA) to sequence a further 34,000 whole human genomes for the VA’s Million Veteran Program (MVP). This brings the total of all Personalis contracts from […]
FUJISAWA CITY, Japan & DUBLIN–GenAhead Bio Incorporated (“GenAhead”) and ERS Genomics Limited (“ERS Genomics”) announced today a non-exclusive license agreement to provide GenAhead with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, co-inventor of the breakthrough gene editing technology. GenAhead had its start […]
FDA employs Certara Phoenix®, Simcyp® and Synchrogenix GlobalSubmit software platforms to efficiently assess and evaluate sponsor submissions data PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
